STEP - Updated Logo Color.png
StepStone Group to Announce Fourth Quarter and Fiscal 2024 Results on May 23, 2024
May 09, 2024 08:05 ET | StepStone Group Inc
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP) today announced that the Company will release its results for the fourth quarter and fiscal year ended March 31, 2024,...
ACELYRIN, INC. Logo.jpg
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
May 09, 2024 08:01 ET | ACELYRIN, INC.
Completed enrollment in izokibep Phase 3 trial in hidradenitis suppurativa and enrollment completion in Phase 2b/3 trial in uveitis expected this month; top line data for both trials now expected by...
sportradar-logo(2).jpg
Sportradar to Participate in the J.P. Morgan Global Technology, Media and Communications Conference on May 21
May 09, 2024 08:00 ET | Sportradar AG
ST. GALLEN, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ: SRAD) (“Sportradar” or the “Company”), a leading global sports technology company, today announced that Carsten...
AL_Intercept_Logo_CMYK.png
Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference
May 09, 2024 08:00 ET | Intercept Pharmaceuticals, Inc.
MORRISTOWN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and...
Fulcrum-Logo_Primary_Full-Color_RGB_Large copy.jpg
Fulcrum Therapeutics to Participate in Upcoming May Conferences
May 09, 2024 08:00 ET | Fulcrum Therapeutics, Inc.
CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to...
ACELYRIN, INC. Logo.jpg
ACELYRIN, INC. Announces Leadership Transition
May 09, 2024 08:00 ET | ACELYRIN, INC.
Mina Kim appointed Chief Executive Officer and to Board of Directors ACELYRIN Founder Shao-Lee Lin, M.D., Ph.D., steps down as Chief Executive Officer Shephard (Shep) Mpofu, M.D., MRCP, FRCP...
perma_fix_logo_02112021.jpg
Perma-Fix Reports Financial Results and Provides Business Update for the First Quarter of 2024
May 09, 2024 08:00 ET | Perma-Fix Environmental Services, Inc
ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced financial results and provided a business update for the first quarter...
image2.png
Shoals Technologies Group Expands Leadership Team with Key Appointments in International Business and Investor Relations
May 09, 2024 08:00 ET | Shoals Technologies Group
PORTLAND, Tenn., May 09, 2024 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc., a leading provider of electrical balance of systems (“EBOS”) solutions for solar, battery storage, and electric...
VERA_Thumbnail.jpg
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
May 09, 2024 08:00 ET | Vera Therapeutics
Presented positive 72-week data from the Phase 2b ORIGIN clinical trial, setting a new standard in IgAN with no loss of kidney function over the duration of treatmentTopline 96-week data from ORIGIN 2...
Rani-Logo.jpg
Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
May 09, 2024 08:00 ET | Rani Therapeutics, LLC
SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...